Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Capital Employed (2021 - 2025)

GeneDx Holdings (WGS) has disclosed Return on Capital Employed for 4 consecutive years, with 0.29% as the latest value for Q2 2024.

  • On a quarterly basis, Return on Capital Employed rose 95.0% to 0.29% in Q2 2024 year-over-year; TTM through Jun 2024 was 0.29%, a 95.0% increase, with the full-year FY2025 number at 0.04%, up 3.0% from a year prior.
  • Return on Capital Employed was 0.29% for Q2 2024 at GeneDx Holdings, up from 0.38% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.29% in Q2 2024 to a low of 3.39% in Q2 2021.
  • A 4-year average of 1.22% and a median of 1.09% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: surged 252bps in 2022, then plummeted -82bps in 2023.
  • GeneDx Holdings' Return on Capital Employed stood at 0.93% in 2021, then crashed by -39bps to 1.29% in 2022, then soared by 61bps to 0.5% in 2023, then skyrocketed by 43bps to 0.29% in 2024.
  • Per Business Quant, the three most recent readings for WGS's Return on Capital Employed are 0.29% (Q2 2024), 0.38% (Q1 2024), and 0.5% (Q4 2023).